Gemetastaseerd plaveiselcelcarcinoom na niertransplantatie

T. Su; E. Rácz; M. J. Crop; K. E. Broekman; M. J. Wiegman

Gemetastaseerd plaveiselcelcarcinoom na niertransplantatie

T. Su^*, E. Rácz, M. J. Crop, K. E. Broekman, M. J. Wiegman

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

56 Downloads (Pure)

Samenvatting

Transplant patients have a higher risk of developing advanced cutaneous squamous cell carcinoma. In case of metastasized or locally advanced disease when curative surgery or radiotherapy is not possible, immune therapy is an option. However, there is a risk of organ rejection due to boosted immune response. We describe a case where complete remission of cutaneous squamous cell carcinoma with pulmonary metastasis in a kidney transplant patient has been achieved with cemiplimab with preservation of transplant function.

Originele taal-2	Dutch
Pagina's (van-tot)	49-51
Aantal pagina's	3
Tijdschrift	Nederlands Tijdschrift voor Dermatologie en Venereologie
Volume	31
Nummer van het tijdschrift	6
Status	Published - jun.-2021

Keywords

cemiplimab
immune therapy
PD-1 inhibitor
squamous cell carcinoma
transplantation

Toegang tot document

Gemetastaseerd plaveiselcelcarcinoom na niertransplantatieFinal publisher's version, 206 KBLicentie: Unspecified

https://nvdv.nl/patienten/dermatologie/zoek-een-dermatoloog/zoek-aan-artikel/oncologie-gemetastaseerd-plaveiselcelcarcinoom-na-niertransplantatie-2021-06Licentie: Unspecified

Handle.net

Permanente koppeling

Citeer dit

@article{fa409f1c86f8479b8feef2c805e15ddb,

title = "Gemetastaseerd plaveiselcelcarcinoom na niertransplantatie",

abstract = "Transplant patients have a higher risk of developing advanced cutaneous squamous cell carcinoma. In case of metastasized or locally advanced disease when curative surgery or radiotherapy is not possible, immune therapy is an option. However, there is a risk of organ rejection due to boosted immune response. We describe a case where complete remission of cutaneous squamous cell carcinoma with pulmonary metastasis in a kidney transplant patient has been achieved with cemiplimab with preservation of transplant function.",

keywords = "cemiplimab, immune therapy, PD-1 inhibitor, squamous cell carcinoma, transplantation",

author = "T. Su and E. R{\'a}cz and Crop, {M. J.} and Broekman, {K. E.} and Wiegman, {M. J.}",

year = "2021",

month = jun,

language = "Dutch",

volume = "31",

pages = "49--51",

journal = "Nederlands Tijdschrift voor Dermatologie en Venereologie",

issn = "0925-8604",

publisher = "DCHG Partners in Mediscne Communicatie",

number = "6",

}

TY - JOUR

T1 - Gemetastaseerd plaveiselcelcarcinoom na niertransplantatie

AU - Su, T.

AU - Rácz, E.

AU - Crop, M. J.

AU - Broekman, K. E.

AU - Wiegman, M. J.

PY - 2021/6

Y1 - 2021/6

N2 - Transplant patients have a higher risk of developing advanced cutaneous squamous cell carcinoma. In case of metastasized or locally advanced disease when curative surgery or radiotherapy is not possible, immune therapy is an option. However, there is a risk of organ rejection due to boosted immune response. We describe a case where complete remission of cutaneous squamous cell carcinoma with pulmonary metastasis in a kidney transplant patient has been achieved with cemiplimab with preservation of transplant function.

AB - Transplant patients have a higher risk of developing advanced cutaneous squamous cell carcinoma. In case of metastasized or locally advanced disease when curative surgery or radiotherapy is not possible, immune therapy is an option. However, there is a risk of organ rejection due to boosted immune response. We describe a case where complete remission of cutaneous squamous cell carcinoma with pulmonary metastasis in a kidney transplant patient has been achieved with cemiplimab with preservation of transplant function.

KW - cemiplimab

KW - immune therapy

KW - PD-1 inhibitor

KW - squamous cell carcinoma

KW - transplantation

M3 - Article

AN - SCOPUS:85167711783

SN - 0925-8604

VL - 31

SP - 49

EP - 51

JO - Nederlands Tijdschrift voor Dermatologie en Venereologie

JF - Nederlands Tijdschrift voor Dermatologie en Venereologie

IS - 6

ER -